Advertisement
Home Tags Cancer: Lung

Tag: Cancer: Lung

DNA-based biomarkers in the nasal passages may be able to reveal whether a lung lesion is cancerous or not

Biomarker in Nasal Passages May ID Lung Cancer in Smokers

0
Simple technique is based on cancer DNA and seems accurate for use after chest CT scan, researchers say
Most current and former smokers in the United States don't get screened for lung cancer even though they're at increased risk for the disease

Lung Cancer Screening Rates Low Among Current, Former Smokers

0
Such testing could cut mortality rate by 20 percent, American Cancer Society says
Many Veterans Health Administration patients are eligible for lung cancer screening (LCS) with low-dose computed tomography

Many VHA Patients Eligible for Lung Cancer Screening

0
Second study shows increase in lung cancer screening from 1.3 to 2.1 percent from 2010 to 2015
Lung cancer screening seems to be underutilized in the community

STS: Lung Cancer Screening Underused in the Community

0
All network providers were aware of the screening program; 15 percent never referred a patient
Many U.S. patients with late-stage non-small-cell lung cancer do not receive treatments that could prolong their lives

Many Advanced NSCLC Patients Not Getting Helpful Treatment

0
Study found 21 percent went without therapy, even though it could boost survival
For older heavy cigarette smokers

Increasing Severity of Airflow Limitation Linked to Lung CA Risk

0
Linear relationship seen in population of older heavy cigarette smokers
Chemotherapy that's been delayed due to slow recovery from non-small-cell lung cancer surgical resection can still provide real benefit to patients

Delayed Chemo After Surgery Still Beneficial in Lung Cancer

0
Patient recovery may mean longer time to chemotherapy, but treatment can still have benefit
From 2000 to 2011 there were shifts in the treatment of advanced-stage non-small-cell lung cancer

2000 to 2011 Saw Shift in Treatment for Advanced NSCLC

0
Rise in use of pemetrexed, erlotinib, bevacizumab; longest treatment duration with these agents
The immunotherapy atezolizumab extends the survival of previously treated non-small-cell lung cancer patients for several months and causes fewer side effects than docetaxel

Atezolizumab Effective in Late-Stage Non-Small-Cell Lung Cancer

0
Drug can extend survival by several months, with fewer adverse events
A stepped care program is likely to be cost-effective for patients with head and neck cancer or lung cancer who have psychological distress

Stepped Care Likely to Be Cost-Effective in Head & Neck, Lung CA

0
Mean costs lower and mean number of quality-adjusted life-years higher in intervention group